cephalothin has been researched along with moxalactam in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (58.06) | 18.7374 |
1990's | 1 (3.23) | 18.2507 |
2000's | 8 (25.81) | 29.6817 |
2010's | 4 (12.90) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brandsch, M; Luckner, P | 1 |
Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I | 1 |
Aubert, D; Naas, T; Nordmann, P; Ozcan, A | 1 |
Girlich, D; Leclercq, R; Naas, T; Nordmann, P | 1 |
Doi, Y; Nordmann, P; Paterson, DL; Poirel, L | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Castanheira, M; Samuelsen, Ø; Spencer, J; Walsh, TR | 1 |
Girlich, D; Nordmann, P; Poirel, L | 3 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Kumano, K; Kuroyama, M; Mashimo, S; Sakai, T; Tomonaga, F | 1 |
Noel, GJ; Teele, DW | 1 |
Johnson, CM; Kang, YJ; Manson, JM; Zolna, LE | 1 |
Berche, P; Gaillard, JL | 1 |
Boelaert, J; Piot, P; Van Landuyt, HW; Verbist, L | 1 |
Cohn, DL; Reimer, LG; Reller, LB | 1 |
McNamara, BT; Meyer, RD; Pasiecznik, KA | 1 |
Gilchrist, MJ; Spelhaug, DR; Washington, JA | 1 |
Lareng, MB; Lefèvre, JC; Prère, MF | 1 |
Durosoir, JL; Saliou, P; Thabaut, A | 1 |
Armengaud, M; Barza, M; Cherubin, CE; Corrado, ML; Landesman, SH; Shah, PM | 1 |
Forsgren, A | 1 |
Bergeron, MG; Simard, P | 1 |
Malottke, R | 1 |
Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN; Sommers, HM | 1 |
Barry, AL; Gerlach, EH; Jones, RN; Thornsberry, C | 1 |
Lentino, JR; Moore, E; Rytel, MW | 1 |
Afarian, J; Ehrlich, SL; Kass, EH; O'Brien, TF; Pennington, JE; Platt, R | 1 |
Eguchi, S; Imaizumi, K; Kanazawa, H; Kosuge, T; Okazaki, H; Sato, Y | 1 |
Carroll, S; Goonetilleke, A; Hargreaves, M | 1 |
1 review(s) available for cephalothin and moxalactam
Article | Year |
---|---|
Past and current roles for cephalosporin antibiotics in treatment of meningitis. Emphasis on use in gram-negative bacillary meningitis.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Blood-Brain Barrier; Cefamandole; Cefotaxime; Cefoxitin; Cephaloridine; Cephalosporins; Cephalothin; Cephamycins; Child, Preschool; Enterobacteriaceae; Female; Humans; Infant; Infant, Newborn; Male; Meningitis; Middle Aged; Moxalactam; Pseudomonas aeruginosa | 1981 |
1 trial(s) available for cephalothin and moxalactam
Article | Year |
---|---|
[A comparison of the penetration characteristics of latamoxef and cephalothin into the right atrial appendage and pericardial fluid of adult patients undergoing open-heart surgery].
Topics: Adolescent; Adult; Aged; Cephalothin; Extracorporeal Circulation; Female; Heart Atria; Heart Diseases; Humans; Injections, Intravenous; Kinetics; Male; Middle Aged; Models, Biological; Moxalactam; Myocardium; Pericardium; Premedication; Time Factors | 1984 |
29 other study(ies) available for cephalothin and moxalactam
Article | Year |
---|---|
Interaction of 31 beta-lactam antibiotics with the H+/peptide symporter PEPT2: analysis of affinity constants and comparison with PEPT1.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Binding Sites; Caco-2 Cells; Dose-Response Relationship, Drug; Humans; Peptide Transporter 1; Protein Binding; Rats; Symporters | 2005 |
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
Topics: Animals; beta-Lactams; Cell Line, Tumor; Dipeptides; Drug Design; Humans; Mammals; Models, Molecular; Oligopeptides; Peptide Transporter 1; Quantitative Structure-Activity Relationship; Substrate Specificity; Symporters | 2005 |
Chromosome-encoded narrow-spectrum Ambler class A beta-lactamase GIL-1 from Citrobacter gillenii.
Topics: beta-Lactamases; Chromosomes; Chromosomes, Bacterial; Citrobacter; Cloning, Molecular; DNA, Bacterial; Escherichia coli; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Genes, Bacterial; Molecular Sequence Data | 2007 |
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
Topics: Amino Acid Sequence; Bacillus; Bacterial Proteins; beta-Lactamases; Chromosome Mapping; Chromosomes, Bacterial; Cloning, Molecular; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Sequence Homology, Amino Acid; Substrate Specificity | 2007 |
Characterization of a naturally occurring class D beta-lactamase from Achromobacter xylosoxidans.
Topics: Achromobacter denitrificans; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cloning, Molecular; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family.
Topics: Acremonium; Bacterial Proteins; beta-Lactamases; Catalysis; Catalytic Domain; Cefepime; Ceftazidime; Cephalosporins; Kinetics; Models, Molecular; Mutation; Penicillinase; Protein Structure, Tertiary; Recombinant Proteins; Structure-Activity Relationship; Substrate Specificity | 2008 |
First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.
Topics: Acinetobacter baumannii; beta-Lactamases; DNA, Bacterial; Escherichia coli; France; Genes, Bacterial; Water Microbiology | 2010 |
Novel ambler class A carbapenem-hydrolyzing beta-lactamase from a Pseudomonas fluorescens isolate from the Seine River, Paris, France.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blotting, Southern; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; France; Fresh Water; Gram-Negative Bacteria; Health Surveys; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Pseudomonas fluorescens; Water Microbiology | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
PER-6, an extended-spectrum beta-lactamase from Aeromonas allosaccharophila.
Topics: Aeromonas; Animals; Base Sequence; beta-Lactamases; DNA Primers; DNA, Bacterial; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Paris; Water Microbiology | 2010 |
[Protein binding of various cephems in healthy subjects and patients with chronic renal failure].
Topics: Adult; Cephalosporins; Cephalothin; Fatty Acids, Nonesterified; Female; Humans; Kidney Failure, Chronic; Lipase; Male; Middle Aged; Moxalactam; Peritoneal Dialysis; Protein Binding; Renal Dialysis; Serum Albumin | 1991 |
In vitro activities of selected new and long-acting cephalosporins against Pasteurella multocida.
Topics: Cefaclor; Cefixime; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephalothin; Cloxacillin; Erythromycin; Humans; Microbial Sensitivity Tests; Moxalactam; Oxacillin; Pasteurella; Penicillin G; Penicillin V | 1986 |
Effects of cefonicid and other cephalosporin antibiotics on male sexual development in rats.
Topics: Age Factors; Animals; Cefamandole; Cefonicid; Cephalothin; Chemical Phenomena; Chemistry; Copulation; Female; Fertility; Injections, Subcutaneous; Male; Moxalactam; Pregnancy; Random Allocation; Rats; Rats, Inbred Strains; Seminiferous Tubules; Sexual Maturation; Sperm Count; Testis | 1987 |
[In vitro activity of cefotaxime, latamoxef and ceftriaxone on hospital strains of Enterobacteriaceae resistant to cefalotine and cefoxitine].
Topics: Cefotaxime; Cefoxitin; Ceftriaxone; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Moxalactam; Species Specificity | 1986 |
In vitro activity of temocillin against clinical isolates.
Topics: Bacteria; Cefotaxime; Cefuroxime; Cephalothin; Gram-Positive Bacteria; In Vitro Techniques; Microbial Sensitivity Tests; Moxalactam; Penicillins | 1985 |
Comparative in-vitro activity of MK0787 (N-formimidoyl thienamycin) against 540 blood culture isolates.
Topics: Anti-Bacterial Agents; Bacteria; Cephalothin; Cephamycins; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Sepsis; Tobramycin | 1982 |
In vitro susceptibility of cephalothin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to Amikacin and selected new beta-lactam agents.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Cefoxitin; Cephalothin; Cephamycins; Drug Resistance, Microbial; Enterobacteriaceae; Kanamycin; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa | 1982 |
Bactericidal activity of antibiotics against Campylobacter fetus subspecies intestinalis.
Topics: Ampicillin; Campylobacter; Campylobacter fetus; Cefoperazone; Cefotaxime; Cephalosporins; Cephalothin; Cephamycins; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Streptomycin | 1981 |
Study of the in vitro activity of new cephalosporins on strains of Neisseria gonorrhoeae of the Toulouse region.
Topics: Ampicillin; Cefazolin; Cefotaxime; Cefotiam; Cefoxitin; Ceftriaxone; Cephalosporins; Cephalothin; Cephamycins; Female; France; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Moxalactam; Neisseria gonorrhoeae; Penicillins | 1981 |
Comparative in vitro activity of 8 cephalosporins on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis.
Topics: Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Ceftriaxone; Cefuroxime; Cephalosporins; Cephalothin; Cephamycins; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Moxalactam; Neisseria gonorrhoeae; Neisseria meningitidis | 1981 |
Comparative in vitro activity of first, second and third generation cephalosporins.
Topics: Bacteria; Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Ceftazidime; Cefuroxime; Cephalosporins; Cephalothin; Cephamycins; Dose-Response Relationship, Drug; Moxalactam; Structure-Activity Relationship | 1981 |
Inoculum size effect on the MIC of cefoperazone, moxalactam, cefotaxime, cefoxitin and cephalothin for 118 strains of Haemophilus influenzae including 'tolerant' micro-organisms.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cefoxitin; Cephalosporins; Cephalothin; Cephamycins; Haemophilus influenzae; Microbial Sensitivity Tests; Moxalactam | 1982 |
[Bacteriological investigations with a new Semisynthetic oxy-beta-lactam antibiotic LY 127935 (AUTHOR'S TRANSL)].
Topics: Bacteria; Cephalosporins; Cephalothin; Cephamycins; Microbial Sensitivity Tests; Moxalactam | 1980 |
Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.
Topics: Acinetobacter; Anti-Bacterial Agents; Bacteria; Cefamandole; Cefoperazone; Cephalosporins; Cephalothin; Cephamycins; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Staphylococcus; Streptococcus | 1980 |
Tentative interpretive standards for disk susceptibility tests with moxalactam (LY127935).
Topics: Cephalosporins; Cephalothin; Cephamycins; Humans; Microbial Sensitivity Tests; Moxalactam | 1980 |
Therapy of lower respiratory tract infections with moxalactam.
Topics: Adult; Aged; Bacteria; Bacterial Infections; Cefamandole; Cephalosporins; Cephalothin; Cephamycins; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Moxalactam; Pneumonia; Species Specificity | 1981 |
Moxalactam therapy of infections caused by cephalothin-resistant bacteria: influence of serum inhibitory activity on clinical response and acquisition of antibiotic resistance during therapy.
Topics: Adult; Bacterial Infections; Cephalosporins; Cephalothin; Cephamycins; Drug Resistance, Microbial; Female; Humans; Microbial Sensitivity Tests; Moxalactam | 1981 |
Sourcing faecal pollution from onsite wastewater treatment systems in surface waters using antibiotic resistance analysis.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Cephalothin; Chlortetracycline; Colony Count, Microbial; Discriminant Analysis; Drug Resistance, Bacterial; Erythromycin; Escherichia coli; Feces; Gentamicins; Humans; Moxalactam; Ofloxacin; Tetracycline; Water Microbiology; Water Pollution | 2005 |